Skip to main content
MapleLMS Implementation
Conferences and Meetings 101. Red Cells and Erythropoiesis, Excluding Iron: Poster III

101. Red Cells and Erythropoiesis, Excluding Iron: Poster III

Short name: 101. Red Cells and Erythropoiesis, Excluding Iron: Poster III
Course start date: 11/09/2025

Sections

General
0 activities

Arginine Metabolism Is a Biomarker of Red Blood Cell and Human Aging
Ex Vivo Glucose Tracing in Red Blood Cells from Patients with Hereditary Xerocytosis Reveals Enhanced Glycolytic Flux
Got Oxygen? the Impact of Band 3 on RBC Function during Exercise
Hereditary Erythrocytosis: Results from Europe's Largest Idiopathic Erythrocytosis Database
Mixed Type Autoimmune Hemolytic Anemia: A Single Center Observational Study
PIEZO1 Gain-of-Function Variants Lead to Alterations in Late-Stage Erythropoiesis By Enhancing Enucleation Rate
Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study
Protein S Enhances the Phagocytosis of Phosphatidylserine-Positive Erythrocyte: Implications for the Erythrocytes Turnover
Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II – Results from the 8-Week Dose-Escalation Period
Sirolimus Plus Roxadustat in Patients with Pure Red Cell Aplasia: Results from a Prospective Multi-Center Clinical Trial
The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune-Antibody-Mediated Hemolytic Anemia
Transcriptional Control of Erythropoiesis Via a Kit-Response Cistrome
ULK1 Regulates the Proliferation and Differentiation of Erythroid Progenitors